9 Months 2 0 0 9 Results Presentation
NI REUS AQUACULTURE S.A.
Athens Greece | 2 7 Novem ber 2 0 09
NI REUS AQUACULTURE S.A. Nireus at a glance The leader in seabass - - PowerPoint PPT Presentation
Athens Greece | 2 7 Novem ber 2 0 09 9 Months 2 0 0 9 Results Presentation NI REUS AQUACULTURE S.A. Nireus at a glance The leader in seabass and seabream fish farm ing - A fully integrated producer - Production facilities in 3
Athens Greece | 2 7 Novem ber 2 0 09
2
2
3
3
expenses reduced by € 7.1 mi. (down 11.6% ) – PPE halved to € 5.9 mi.
4
4
Recovery of the price of seabream despite higher volum es Depleting inventories expected to sustain price at higher level
MercaMadrid - Monthly volum es for fresh farm ed Seabream
100 200 300 400 500 600 700 800 900 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
tonnes 2008 2009 Seabass (Sparus aurata) Seabass (Sparus aurata)
MercaMadrid - W holesale Prices for Fresh farm ed Seabream last update 21/ 11/ 2009
3,00 3,50 4,00 4,50 5,00 5,50 6,00 6,50 7,00 7,50 8,00 8,50 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50
EURO / kg
2008 2009
5
5
Price at 20 08 levels w ith higher volum es
MercaMadrid - Monthly volum es for fresh farm ed Seabass
50 100 150 200 250 300 350 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
tonnes
2008 2009
Seabass (Dicentrarchus labrax) Seabass (Dicentrarchus labrax) MercaMadrid - W holesale prices for fresh farmed Seabass la st upda te 2 1 / 1 1 / 2 0 0 9
4,50 5,00 5,50 6,00 6,50 7,00 7,50 8,00 8,50
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50
2 0 0 8 2 0 0 9
6
6
Aggregate cost of raw m aterials used for the production of fish feed stable vs 200 8
Data Source : FAO
Monthly Soybean Meal
(pellets, 44/45%, cif Rotterdam)
200 250 300 350 400 450 500 550 Jan Feb Mar Apr M ay Jun Jul Aug Sep Oct Nov Dec
2007 2008 2009
Monthly Fish Oil
(cif North West Europe)
400 800 1.200 1.600 2.000 Jan Feb M ar Apr M ay Jun Jul Aug Sep Oct Nov Dec
2007 2008 2009
Monthly Fish Meal
(64/65% Bremen fca)
900 1.000 1.100 1.200 1.300 1.400 1.500 Jan Feb M ar Apr M ay Jun Jul Aug Sep Oct Nov Dec
2007 2008 2009
7
7
12 170 220 229 260 290 310 310 315 320 329 329 329 329 100 200 300 400 1985 1995 2000 2002 2004 2006 2008
12 110 140 140 170 185 190 205 193 248 260 175 167 125 106 80 50 100 150 200 250 300
1 9 8 5 1 9 9 1 9 9 1 1 9 9 2 1 9 9 3 1 9 9 4 1 9 9 5 1 9 9 6 1 9 9 7 1 9 9 8 1 9 9 9 2 2 3 2 6 2 8 2 9
Data Source : Federation of Greek Mariculture
Greek Production - thou ton
0,1 1,6 17 59 79 98 97 82 85 100 120 130 120 20 40 60 80 100 120 140 1985 1990 1995 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Stable capacity since 2 0 0 6 ( NO new licenses) 8 0 com panies in 2 0 0 9 vs 1 6 7 com panies in 20 0 6 Hellastat expects a further reduction in production to 1 1 0 thou. ton. in 2 0 1 0
( analysis of the Greek fish farm ing sector, Oct 2 0 09 )
8
8
in m i. €
9M 20 09 9 M 2008 200 8 Total non-current 253,27 246,23 293,27 Total current 269,77 268,41 231,16 Total assets 523,0 4 514,6 5 52 4,43
in m i. €
9M 20 09 9 M 2008 200 8 Total shareholders' equity and m inority interests 170,79 170,23 168,27 Total non-current liabilities 213,07 214,07 217,47 Total current liabilities 139,18 130,34 138,69 Total liabilities 352,24 344,42 356,16 Total equity and liabilities 523,0 4 514,6 5 52 4,43
9
9
in mi. € 9M 2 00 9 9 M 20 08 20 08 Biological Sales 9 2,3 9 5,6 111 ,9 8 Non-Biological Sales 3 3,6 3 5,8 5 7,7 7 Total Sales 12 5,9 1 31,4 169 ,7 5 Gain from change of Fair Value in Biological Assets 1 17 ,9 2 125 ,5 7 160 ,8 0 EBI TDA 20 ,6 3 1 9,7 5 2 9,9 1 EBI T Operating 14 ,6 3 1 4,4 6 2 2,9 5 EBT 6 ,2 6 6 ,4 5 9 ,7 8 Tax
EAT 2 ,3 2 1 ,4 2 1 ,1 3 Majority interest 1 ,7 4 0 ,4 5 0,32 Minority interest 0 ,5 8 0 ,9 8 0,81 Earnings per share 0,0273 0,0087 0,0058
Reduced sales of feed and juveniles to farm ers im pacted overall sales Fish sales up + 9 .6 % in value
1 0
1 0
Strong reduction in sustaining capex
in mi. € 9 M 20 0 9 9 M 2 00 8 2 0 0 8 Profit before tax 6,26 6,45 9,78 Cash flow from operating activities
Cash flow from investing activities
Cash flow from financing activities 2,16 9,25 1 6 ,7 4 Total cash flow reporting period
Cash and cash equivalents at the beginning of the period 29,64 51,90 51,90 Cash and cash equivalents at the end
15 ,4 7 2 9,28 2 9 ,6 4
1 1
1 1
in m i. € 9 M 2 0 0 9 9 M 2 0 0 8 2 0 0 8 Operating revenues 125,87 131,40 169,75 EBI TDA 2 0 ,6 3 1 9 ,7 5 2 9 ,9 1 EBITDA m argin(% ) 16% 15% 18% EBT 6 ,2 6 6 ,4 5 9 ,7 8 EBT m argin(% ) 5% 5% 6% Earnings after tax & m inorities 1 ,7 4 0 ,4 5 0 ,3 2 Earnings per share 0,0273 0,0087 0,0058 Total assets 523,04 514,65 524,43 Equity 170,79 170,23 168,27
1 2
1 2
Volum es in m arket-size fish increased by 15.4% Sales of feed and juveniles w ere reduced on stricter credit term s
0.22 58.5 0.97 21.4 4.54 18.1 9M 20 08 0.21 62.4 0.95 28 4.43 24 20 08 38 36.7 Juveniles
( m i. pieces)
20 17.5 Fish Feed ( thou. ton.) 0.93 0.93
( € / kg)
28 20.9 Market-size fish ( thou. ton.) 4.30 4.30
( € / kg)
20 09e 9M 20 09 0.21 0.21
( per piece)
96 98 21 16 15 12 Fish Farming Fish Feed Other
9Μ Sales by Sector for 2008 & 2009 (mi. €)
9M 2008 9M 2009 Fish farming = fish + juveniles sales Other = equipment to fish farmers + feed, health, breeding and equipment to aviculture and animal culture
1 3
1 3
m i. € + 9 .6% 9 0 .2 8 2 .2 Δ% 9 M 20 09 9 M 20 08 m i. € + 1 3 .1 % 3 0 .1 2 6 .7 Δ% 3 Q 2 00 9 3 Q 2 00 8 9Μ 2008 9Μ 2009 35,7 90,2 82,2 49,2
0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0
Fish Sales (mi. €) Ot her sales (mi. €) 3Q 2008 3Q 2009 11,2 30,1 26,7 17,3
,0 ,0 ,0 ,0 ,0 ,0
Fish Sales (mi. €) Ot her sales (mi. €)
1 4
1 4
4 4,5 5 5,5 6 6,5 7 7,5 2008 1Q 2008 2Q 2008 3Q 2008 4Q 2009 1Q 2009 2Q 2009 3Q
Fish Sales Volume ('000 T) - 2008-2009 - quarterly
‘0 0 0 T 1 5 .4 % 2 0 .9 1 8 .1 Δ% 9 M 20 09 9 M 20 08 ‘0 0 0 T 1 5 .4 % 6 .8 5 .9 Δ% 3 Q 2 00 9 3 Q 2 00 8
8,0 10,0 12,0 14,0 16,0 18,0 20,0 22,0 24,0 26,0 28,0 2004 2005 2006 2007 2008 2009e
Fish Sales Volume ('000 T) - 2003-2009e
1 5
1 5 18,64 21,26 3M 2008 3M 2009
61,06 53,96 9M 2008 9M 2009
Group
in mi. € 9 M 2 0 0 9 9 M 2 0 0 8 Salaries & personnel expenses 25,21 27,97 3rd party fees and benefits 15,83 17,17 Other expenses 12,92 15,92 3 Q 2 0 0 9 3 Q 2 0 0 8 Total 5 3 ,9 6 6 1 ,0 6 1 8 ,6 4 2 1 ,2 6 Total as % of sales 4 2 ,8 7 % 4 6 ,4 7 % 4 5 ,0 2 % 4 8 ,3 4 %
1 6
1 6 15,02 17,62 3M 2008 3M 2009 51,71 43,85 9M 2008 9M 2009
Com pany
9 M 2 0 0 9 9 M 2 0 0 8 Salaries & personnel expenses 19,44 22,39 3rd party fees and benefits 12,86 15,00 Other expenses 11,54 14,32 3 Q 2 0 0 9 3 Q 2 0 0 8 Total 4 3 ,8 5 5 1 ,7 1 1 5 ,0 2 1 7 ,6 2 Total as % of sales 3 5 ,0 9 % 3 7 ,7 6 % 3 4 ,4 1 % 3 5 ,9 0 %
1 7
1 7
Gutted bream , gutted bass and bream fillets launched in the Greek subsidiary of MAKRO hyperm arket under the brand nam e THALASSA ( SEA in Greek) .
1 8
1 8
Source for fish feed volum es: Kontali Analyse
Fish feed grow th for seabass/ seabream has been negative since Nov 2 008 Less dem and for fish feed ⇒low er fish population ( biom ass) ⇒reduction in future fish supply ⇒better expected pricing
Growth of fish feed production for seabass/seabream - 3M average Oct 2009
0% 10% 20% 30% 40% Mar-06 Jul-06 Nov-06 Mar-07 Jul-07 Nov-07 Mar-08 Jul-08 Nov-08 Mar-09 Jul-09
Fish feed sales to seabass/seabream producers
10.000 20.000 30.000 40.000 50.000 60.000 70.000 80.000 90.000 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2008 2009
1 9
1 9 SEABASS Monthly Price and Volume Evolution Jan 1996 - Oct 2009 (source: MercaMadrid)
90.000 180.000 270.000 360.000
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Volume (kg)
3,50 10,50 17,50 Price
Volume Price
Extrem e highs and low s in seabass/ seabream prices occur in a 7 - 8 years cyclical pattern that has a strong negative correlation w ith volum e grow th and a w eaker link w ith GDP grow th. Low er production volum es = > better pricing SEABREAM Production is less consolidated = > volatile pricing pattern Record high volum es in 2 0 0 8 - 2 0 0 9 = > historical low spring of 2 0 0 9 Reduced volum es are expected for 2 0 1 0 because of low prices SEABASS Production is m ore consolidated = > less volatility y- o-y Volum es have increased in 2 0 0 9
SEABREAM Monthly Price and Volume Evolution Jan 1996 - Oct 2009 (source: MercaMadrid)
300.000 600.000 900.000
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Volume (kg) 3,00 5,00 7,00 9,00 11,00 Price
Volume Price
2 0
2 0
fish sales volum e up 1 5 .4% in 9 Μ 09
new brand launched
France, Spain new logistics center in Milan
integrated farm ing clusters applied for relocation of several farm ing units
2 1
2 1
Fish feed Fish feed Juveniles Juveniles Fish Fish
Sales Sales Sales grow th potential Sales grow th potential Capacity Capacity
Capacity: 3 5 .60 0 t
Utilization of full capacity does not require significant CAPEX expenditure Ready to increase production volum es as soon as the sector situation show s further im provem ent % of 20 08 Revenues % of 20 08 Revenues
Sales 07: 2 6.40 0 t Sales 08: 2 4.00 0 t
+ 4 8 %
Capacity: 2 0 0 m i. pieces Capacity: 9 0 .00 0 t Sales 0 7 : 7 7 m i. pieces Sales 0 8 : 6 2 m i. pieces
+ 1 0 0 % + 2 0 %
6 0 %
Sales 0 7 : 4 5 .300 t Sales 0 8 : 2 8 .000 t
8 % 1 6 %
* 9 Months 2 0 0 9 sales: Fish 2 0 .9 0 0 t, juveniles 3 6 .7 m i. pieces, fish feed 1 7 .5 0 0 t
2 2
2 2
Harvest Weight
Normal Operations Operations + Disease + Mortality Operations + Disease
Cost per kg
Δcost - Mortality Δcost - Disease Δcost - Weight
m ortality
2 3
2 3
Fish farming companies are required to calculate and report the fair value of their biomass (IAS 41). The fair value of the biomass is calculated as volume (kg) x market price and is adjusted for the part that is not ready to harvest. The key drivers are the volume and weight of the biomass and the market price at the time of the calculation. The ready to harvest part of the end-of-period biomass is reported in the B.S. as a current asset and the not ready to harvest as a non-current asset. Sales in the I.S. are separated into biological and non- biological. Biological sales represent sales of juveniles and fish (raw and processed) produced by the company. Non- biological sales represent the sales of the fish/ juveniles produced by others, the sales of fish feed, equipment, and other products. The gain or loss arising from changes in the fair value
biomass at end of period (+) biological sales (-) biomass at beginning of period (-) purchases of eggs and juveniles for production = gain/loss from biomass
Biological + Non-biological
Total Sales ( I .S.)
The sales of fish/ juveniles produced by others, fish feed, nets,
Non-biological sales ( I .S.)
The sales of fish/ juveniles produced by the com pany – to include processed fish
Biological Sales ( I .S.)
Δ Volum e Δ Price
Key Drivers
Volum e x Price
Fair value of biom ass ( B.S.)
2 4
2 4
I nvestor Relations
Email m.kotsovou@nireus.com
Financial Calendar 2 00 9
FY 2008 Results Monday, 30 March 2009 3 Mo. 2009 Results: Friday, 29 May 2009 Ordinary AGM: Friday, 19 June 2009 6 Mo 2009 Results: Friday, 28 August 2009 9 Mo 2 0 0 9 Results: Friday, 2 7 Novem ber 2 0 0 9
Legal Notice
This presentation has been prepared solely for inform ational purposes. Any projections or other estim ates in this presentation, including estim ates of returns or perform ance, comm ents w ith respect to our objectives and strategies, or the results
assumptions that m ay be w rong. These assumptions m ay be influenced by factors w ithin or beyond our control, and actual results m ay differ m aterially from any estim ates and projections. Factors influencing actual results include but are not lim ited to fluctuations in fish prices and raw m aterial prices, the effects of competition in the areas in w hich w e operate, changes in the econom ic environm ent, regulatory and econom ic conditions. This presentation is not an offer to buy or sell
in any trading strategy. No part of this presentation m ay be construed as constituting investm ent advice or a recom m endation to enter into any transaction. No representation or w arranty is given w ith respect to the accuracy or completeness
future offer to transact any securities w ill conform to any terms that m ay be contained herein. Before entering into any transaction, investors should determ ine any econom ic risks and benefits, as w ell as any legal, tax and accounting consequences of doing so, as w ell as their ability to assum e such risks, w ithout reliance on the inform ation contained in this presentation.
2 5
2 5